Inventor · disambiguated record
Stephen Connolly
Also filed as: CONNOLLY STEPHEN
32 granted patents·22 pending applications·173 citations·filing 2001–2025
97Inventor score
Top patents by PatentIndex Score
54 records- 0198US12054465B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2023·Granted Aug 6, 2024·3 cites·21 claims
- 0298US11814359B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Nov 14, 2023·4 cites·21 claims
- 0398US11773069B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Oct 3, 2023·6 cites·23 claims
- 0498US11680049B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 20, 2023·5 cites·14 claims
- 0598US11117874B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2020·Granted Sep 14, 2021·15 cites·60 claims
- 0698US10669245B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2019·Granted Jun 2, 2020·16 cites·16 claims
- 0798US9815805B2Certain (25)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2016·Granted Nov 14, 2017·22 cites·14 claims
- 0897US11673871B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·20 claims
- 0997US11673872B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·14 claims
- 1097US11667615B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2021·Granted Jun 6, 2023·5 cites·15 claims
- 1197US11655222B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1297US11655221B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·22 claims
- 1397US11655223B2Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·21 claims
- 1497US11655224B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1597US10287258B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2017·Granted May 14, 2019·18 cites·6 claims
- 1697US9522894B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2015·Granted Dec 20, 2016·25 cites·8 claims
- 1791US2024336582A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1888US7700782B2Compounds 569ASTRAZENECA AB·Filed 2007·Granted Apr 20, 2010·11 cites·3 claims
- 1987US2023250071A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 2083US2024041896A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 2181US8735413B2CompoundCONNOLLY STEPHEN·Filed 2012·Granted May 27, 2014·7 cites·12 claims
- 2277US2022133737A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 2374US2025228870A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2025·Application pending·0 cites
- 2468US2018028541A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors for treating bronchiectasisASTRAZENECA AB·Filed 2017·Application pending·0 cites
- 2566US2020179398A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2019·Application pending·0 cites
- 2665US7119122B2Compounds for the inhibition of nitric oxide synthaseASTRAZENECA AB·Filed 2002·Granted Oct 10, 2006·2 cites·12 claims
- 2765US2019091236A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 2863US6887871B2Use of phenylheteroakylamine derivativesASTRAZENECA AB·Filed 2001·Granted May 3, 2005·2 cites·6 claims
- 2961US6900243B2Phenylheteroalkylamine derivativesASTRAZENECA AB·Filed 2001·Granted May 31, 2005·1 cites·16 claims
- 3060US6953797B2Use of phenylheteroalkylamine derivativesASTRAZENECA AB·Filed 2001·Granted Oct 11, 2005·1 cites·7 claims
- 3159US10954211B2Chemical compoundsASTRAZENECA AB·Filed 2019·Granted Mar 23, 2021·0 cites·11 claims
- 3259US9221782B2CompoundASTRAZENECA AB·Filed 2014·Granted Dec 29, 2015·0 cites·5 claims
- 3355US10336725B2Chemical compoundsASTRAZENECA AB·Filed 2017·Granted Jul 2, 2019·0 cites·3 claims
- 3455US2010056508A1Amine derivatives and their use in beta-2-adrenoreceptor mediated diseasesASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 3554US8017602B2N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(phenethoxy)propanamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapyASTRAZENECA AB·Filed 2009·Granted Sep 13, 2011·0 cites·12 claims
- 3653US7276528B2Compounds for the inhibition of nitric oxide synthaseASTRAZENECA AB·Filed 2006·Granted Oct 2, 2007·0 cites·12 claims
- 3753US2012142646A1Novel Compounds 621ALCARAZ LILIAN·Filed 2007·Application pending·0 cites
- 3850US9975881B2CompoundASTRAZENECA AB·Filed 2015·Granted May 22, 2018·0 cites·2 claims
- 3949US9873678B2Chemical compoundsASTRAZENECA AB·Filed 2015·Granted Jan 23, 2018·0 cites·4 claims
- 4049US2010144606A1Combination 408ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 4146US2009215807A1Novel Diazaspiroalkanes and Their Use for Treatment of CCR8 Mediated DiseasesCONNOLLY STEPHEN·Filed 2006·Application pending·0 cites
- 4245US2006194847A1Novel 6-substituted 2-aminopyridine derivativesCHESHIRE DAVID·Filed 2004·Application pending·0 cites
- 4345US2006270714A1Novel n-substituted 2-aminopyridine derivativesCHESHIRE DAVID·Filed 2004·Application pending·0 cites
- 4444US2009221653A17-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4544US2011053969A1Novel diazasipiroakanes and their use for treatment of ccr8 mediated diseasesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4642US7223794B2Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthaseASTRAZENECA AB·Filed 2002·Granted May 29, 2007·0 cites·21 claims
- 4741US2007249648A1Novel Diazaspiroalkanes and Their Use for Treatment of Ccr8 Mediated DiseasesBLADH HAAKAN·Filed 2004·Application pending·0 cites
- 4841US2010249200A1Novel Compounds 569CONNOLLY STEPHEN·Filed 2010·Application pending·0 cites
- 4940US7119109B2Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthaseASTRAZENECA AB·Filed 2002·Granted Oct 10, 2006·0 cites·15 claims
- 5040US2009156575A1Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseasesBORJESSON LENA·Filed 2006·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen Connolly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →